Introduction
Help Shape the Future of Cancer Care
You’re invited to take this short 5-minute survey for the GUIDE.MRD project. We’re working to improve the use of a blood test (called ctDNA) that can detect small traces of cancer remaining after treatment—known as minimal residual disease (MRD). This can help spot if cancer is coming back early, so patients get the right care and avoid treatments they don’t need.
Your feedback will help us improve our draft system map of how this testing could be implemented in real life. It will also shape recommendations to make cancer care more patient-focused. A public report with the results will be shared later this year.
Before you start:
Please take a moment to look through the short presentation. It gives helpful background that will make the survey easier to answer.
Before you start:
Please take a moment to look through the short presentation. It gives helpful background that will make the survey easier to answer.
Quick things to know:
- Survey must be completed in one-go.
- Your answers are anonymous, confidential and protected.
Thank you for helping make cancer care more personalised and people-centered.